Introduction
Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure patients, affecting millions worldwide. 1 Although there are features common to all HFpEF patients, there may be substantial pathophysiologic heterogeneity as well. 2 Heart failure with preserved ejection fraction is initially defined by an elevation in left-sided filling pressures, but many patients progress to develop pulmonary vascular disease (PVD) secondary to chronic left heart congestion. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] This cohort experiences worse outcomes when compared to
HFpEF patients with isolated left heart disease, but the mechanisms explaining this observation remain poorly understood. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Patients with HFpEF universally complain of exertional intolerance, but the causes may differ between patients with different phenotypes. Exercise introduces an impressive stress to the right heart and lungs, where elevations in venous return increase pulmonary blood volume by 50% while increasing lung blood flow 300%. 15 The healthy pulmonary vasculature is a high compliance, low resistance circuit that can readily accommodate these marked increases in blood volume and flow. 4, 16 However, this reserve may be compromised in patients with HFpEF and PVD, which may lead to important differences compared to HFpEF patients with left heart disease and no PVD. We performed invasive haemodynamic exercise testing with expired gas analysis in a well-defined cohort of HFpEF patients with and without PVD. We hypothesized that the presence of PVD in HFpEF would compromise the ability of the right heart and lungs to accommodate increased blood flow during exercise, increasing ventricular interaction, limiting right ventricular (RV) reserve, and impairing aerobic capacity.
Methods
Consecutive patients who underwent invasive haemodynamic exercise testing at the Mayo Clinic in Rochester, MN, USA between 2006 and 2016 were identified. The Mayo Clinic Institutional Review Board approved the study, and all subjects provided written informed consent. All authors had full access to the data and take full responsibility for its integrity.
Heart failure with preserved ejection fraction was defined by the presence of typical symptoms (exertional dyspnoea and fatigue), left ventricular ejection fraction (LVEF) > _50%, and elevated left-sided filling pressures at rest [pulmonary capillary wedge pressure (PCWP) >15 mmHg]. 17 Heart failure with preserved ejection fraction patients with normal resting PCWP, but elevated PCWP on exercise were not included. To investigate exercise haemodynamics according to the presence of PVD, we divided HFpEF patients into pulmonary hypertension (PH) subgroups according to published recommendations: (i) non-PH [mean pulmonary artery pressure (PAP) <25 mmHg], (ii) PH with no PVD [isolated post-capillary PH, IpcPH; mean PAP > _25 mmHg with pulmonary vascular resistance (PVR) < _3.0 Wood units (WU) and diastolic pressure gradient (DPG) <7 mmHg], and (iii) PH with PVD (combined post-and pre-capillary PH, CpcPH; mean PAP > _25 mmHg with PVR > 3.0 and/or DPG > _7 mmHg). 18 Patients with LVEF <50%, primary right-sided HF, valvular heart disease (>moderate left-sided regurgitation and/or >mild stenosis), unstable coronary artery disease or recent revascularization, constrictive pericarditis, high-output heart failure, and infiltrative, restrictive or hypertrophic cardiomyopathy were excluded.
Echocardiography
Echocardiography was performed at rest in a blinded fashion according to the guidelines of the European Association of Cardiovascular Imaging and the American Society of Echocardiography to assess LV diastolic function, mass, and severity of valvular heart disease. 19, 20 Left ventricular ejection fraction was assessed using quantitative measures based upon optimal images in each patient, including two-dimensional echocardiography using the Quinones formula from the parasternal views (n = 107), the two-dimensional biplane volumetric Simpson method (n = 23), Mmode (n = 2), or visual qualitative assessment (n = 29) if quantitative measurements could not be made. Using RV-focused views, RV basal and mid-cavity dimensions were measured at end-diastole, and RV enddiastolic and end-systolic areas were traced to calculate fractional area change (FAC = [RV end-diastolic area -end-systolic area]/end-diastolic area Â 100). 21 Pericardial restraint and ventricular interaction were assessed by the LV eccentricity index measured at end-diastole as recently described. 22 An LV eccentricity index >1.0 indicates a leftward septal shift due to right-sided overload and enhanced ventricular interdependence.
Cardiac catheterization protocol
Patients were assessed on chronic medications, in fasted state, after minimal sedation and in supine position, without knowledge of echocardiography data, as previously described. [22] [23] [24] [25] [26] Right heart catheterization was performed through a 9-Fr sheath via the right internal jugular vein at both rest and with exercise, with simultaneous directly measured oxygen consumption (VO 2 ) using expired gas analysis (MedGraphic, St. Paul, MN, USA). Right atrial pressure (RAP), PAP, and PCWP were recorded at end-expiration, using the mean of > _3 beats. Pressure tracings were digitized (240 Hz) and stored for offline analysis, performed in a blinded fashion. The left ventricular transmural pressure (LVTMP), which quantifies the net distending pressure that determines LV preload, was calculated as PCWP minus RAP. 22, [27] [28] [29] [30] Arteriovenous oxygen difference (A-VO 2 diff) was determined from directly measured arterial and mixed venous O 2 contents from blood sampling (saturation Â haemoglobin Â 1.34 Â 10). Cardiac output (CO) was determined by the direct Fick method (CO = VO 2 /A-VO 2 diff) and indexed for body surface area to calculate cardiac index (CI). Pulmonary vascular resistance [PVR = (mean PAP -PCWP)/CO] and systemic vascular resistance [SVR = (mean arterial blood pressure -RAP)/CO], stroke volume (SV = CO/heart rate), systemic and pulmonary pulse pressure, and diastolic pressure gradient (DPG = PA diastolic -PCWP) were calculated. Pulmonary arterial compliance (PAC) and total arterial compliance (TAC) were calculated (PAC = SV/pulmonary pulse pressure; TAC = SV/systemic pulse pressure, respectively). 25, 31 Total pulmonary resistance (TPR) was calculated as the quotient of mean PAP and CO. 32 End-systolic pressure (ESP) was taken as 0.9 Â systolic blood pressure. Systemic and pulmonary arterial elastance (Ea-S, Ea-P) were calculated as ESP/SV and PA systolic pressure/SV, respectively. Following rest measures, patients engaged in supine cycle ergometry starting at 20 W workload and increasing in 10-20 W increments (3 min per stage) until subject-reported exhaustion. Haemodynamic data were again acquired at peak exercise in all participants using the same methods.
Statistical analysis
Data are reported as mean ± standard deviation (SD), median (25th, 75th percentile) or numbers (percentages). For each parameter, betweengroup differences were first assessed using the one-way analysis of variance (ANOVA), Kruskal 
Results
Of patients with HFpEF (n = 161), the vast majority (n = 140, 87%) displayed PH (i.e. mean PA pressure > _ 25 mmHg) at rest. Of this group, 68% (n = 95) displayed IpcPH and 32% (n = 45) had CpcPHHFpEF. All CpcPH patients displayed elevated PVR (>240 dynes/ s Â cm 5 ), but only 11 (24%) displayed elevated DPG. Of the total cohort, 50% were examined from 2006 to 2013 and 50% from 2013 to 2016. Sensitivity analysis performed separately among patients in the two eras showed similar results, suggesting that the length of the inclusion period did not significantly influence the results (Supplementary material online, Table S1 ).
Age, sex, body mass index, and body surface area were similar across groups ( Table 1 ). The prevalence of AF and N-terminal pro-B-type natriuretic peptide levels were highest in CpcPH-HFpEF but other comorbidities and medication use were similar across groups. Data are mean ± standard deviation, median (25th, 75th percentile), or n (%). Final column reflects overall group differences. No adjustment for multiple hypotheses testing of different variables was performed. Table S2 ).
Cardiac structure, function, and haemodynamics at rest
Left ventricular dimensions, mass and EF were similar across HFpEF groups ( Table 1) . Heart failure with preserved ejection fraction patients with PH displayed higher E/e 0 . Patients with CpcPH displayed more RV systolic dysfunction compared to the other groups, reflected by lower FAC ( Figure 1A ). Right ventricular dimensions tended to be increased in CpcPH, and tricuspid regurgitation (TR) was more prevalent. The LV eccentricity index tended to be increased in CpcPH-HFpEF patients with PH, indicating greater flattening of the interventricular septum towards the left ventricle at rest and thus greater ventricular interdependence ( Table 1) . There were no differences in heart rate or blood pressures between the groups ( Table 2 ). Right atrial pressure was similar among HFpEF patients with and without PH at rest. There were no statistically significant differences in RAP/PCWP ratio and LVTMP between groups at rest.
Patients with CpcPH-HFpEF displayed more deranged RV-PA coupling, with greater reduction in RV FAC and more RV dilatation as resting PVR increased ( Figure 1B, C) . Patients with CpcPH-HFpEF also displayed increased Ea-P, lower PA compliance, and reduced stroke volume and CI at rest, with a higher A-VO 2 difference ( Table  2) . Patients with HFpEF and PH (regardless of PVD) displayed increased RV stroke work index, reflecting the greater pressurevolume work needed to eject blood through the pulmonary vasculature in the setting of PH. CpcPH-HFpEF patients also displayed increased systemic vascular stiffening, with higher SVR and Ea-S, and lower TAC ( Table 2) .
Exercise haemodynamics
Exercise capacity was reduced in HFpEF patients with PH, evidenced by lower work load achieved and decreased peak VO 2 ( Table 3) . Cardiac output, which by definition is equal to venous return to the right heart at steady state, increased similarly with exercise in non-PH and IpcPH-HFpEF but was lower for any exercise workload in CpcPH-HFpEF ( Figure 2A) . All groups displayed similar absolute increases in PCWP with exercise, though PCWP elevation occurred at lesser cardiac output or venous return in CpcPH-HFpEF (Table 3, Figure 2B ).
Pulmonary artery pressures increased in all groups with exercise, but the greatest increases were observed in the CpcPH group, with higher pressures relative to blood flow (Table 3, Figure 2C ). Patients in the CpcPH-HFpEF group experienced greater reduction in PA compliance on exercise along with higher exercise PVR and Ea-P, in keeping with impaired pulmonary vascular reserve (Table 3, Figure 2D ).
Despite similar RAP at rest, both PH-HFpEF groups developed greater increases in RAP during exercise ( Table 3 ). The intolerance of the right heart and pulmonary circulation to elevation in venous return during exercise was most dramatic in CpcPH-HFpEF ( Figure 3A) .
Increases in right heart congestion may compromise left heart filling in the setting of ventricular interdependence. Patients with non-PH-HFpEF and IpcPH-HFpEF displayed an increase in LV transmural filling pressures, with stable RAP/PCWP ratio during exercise, indicating that left heart congestion was the major pathophysiological driver ( Figures 3B and 4B ). In striking contrast, patients with CpcPHHFpEF developed a paradoxical decrease in LVTMP as venous return to the right heart increased during exercise ( Figure 3B) , with an increase in RAP/PCWP ratio ( Figure 4B) .
The reduction in LVTMP was increased as exercise PVR and transpulmonary gradient (TPG) increased, indicating that left heart underfilling was directly related to the severity of PVD present ( Figure 3C, D) . This was likely related to greater increase in RAP, which was amplified to greater extent as PA compliance decreased in CpcPH-HFpEF ( Figure 4A ). Thus, even as hydrostatic pressures in the pulmonary capillaries increased with exercise in CpcPH-HFpEF patients, there was effective under-distention of the LV. This reduction in LVTMP was coupled with the impairment in cardiac output in CpcPH-HFpEF (Figure 2A) , explained by a reduction in stroke volume, which actually decreased with exercise in CpcPH-HFpEF, even as PA pulse pressure increased, emphasizing the marked limitation in PA compliance ( Figure 4C ). Right ventricular systolic reserve was impaired in both of the PHHFpEF groups, manifest by a blunted ability to augment RV stroke work index during exercise ( Figure 4D ).
Discussion
This is the first comprehensive evaluation of exercise haemodynamics in a well-defined cohort of patients with invasively verified HFpEF with and without PVD. We demonstrate that HFpEF patients with CpcPH displayed multiple features consistent with more advanced HF, including greater RV dysfunction, higher natriuretic peptide levels, and greater burden of atrial fibrillation. CpcPH-HFpEF patients displayed more abnormal RV-PA arterial interaction at rest, with greater chamber dilation and dysfunction as PVR increased. Despite similar biventricular filling pressures at rest, patients with CpcPH-HFpEF developed more dramatic increases in right heart filling pressures as venous return increased during exercise, resulting in enhanced ventricular interdependence, which compromised the transmural distending pressures that drive LV chamber filling. Together with reduced RV contractile reserve, this led to decreases in stroke volume and blunted ability to augment cardiac output with exercise in patients with CpcPH-HFpEF, which was associated with profound impairment in aerobic capacity. These data show that HFpEF patients with PVD demonstrate unique pathophysiologic features brought about by the stress of exercise that distinguish them from HFpEF patients without PVD, including impaired ability to enhance blood flow through the lungs, greater right heart congestion, failure to optimally utilize Frank-Starling reserve in the LV due to ventricular interaction, and limited capacity to augment RV Data are mean ± standard deviation. Final column reflects overall group differences. No adjustment for multiple hypotheses testing of different variables was performed. BP, blood pressure; CpcPH, combined post-and pre-capillary pulmonary hypertension; Ea, effective arterial elastance; Ea-P, pulmonary arterial elastance; Ea-S, systemic arterial elastance; HFpEF, heart failure with preserved ejection fraction; IpcPH, isolated post-capillary pulmonary hypertension; LVTMP, left ventricular transmural pressure; PA, pulmonary artery; PAC, pulmonary arterial compliance; PCWP, pulmonary capillary wedge pressure; PH, pulmonary hypertension; PVR, pulmonary vascular resistance; RA, right atrial; RAP, right atrial pressure; RVSW, right ventricular stroke work; SVR, systemic vascular resistance; TAC, total arterial compliance; TPR, total pulmonary resistance. 
Pulmonary vascular disease in heart failure with preserved ejection fraction
Accumulating evidence supports the idea that there may be pathophysiologically unique phenotypes within the broader population of patients with HFpEF. 2 The presence of PH and PVD appears to identify one such phenotype of importance. [5] [6] [7] [8] [9] [10] [11] Prior studies have begun to characterize PVD in HFpEF clinically and haemodynamically based upon resting data. 10, 12, 14 Similar to the current data, these studies demonstrated that the presence of PVD in patients with HFpEF is associated with reduced exercise capacity, more severe RV dysfunction, and worse outcomes, but the mechanisms have remained unclear. We observed that PVD in HFpEF is associated with more severe systemic arterial disease, reflected by higher mean vascular resistance and arterial elastance, and lower TAC in patients with CpcPH. This might be related in part to interdependence between the great vessels. 33 Alternatively, combined systemic and PA stiffening may be related to widespread loss of NO bioavailability in both the lungs and systemic vasculature. 34 Systemic vascular stiffening in HFpEF is correlated with more severe exercise-induced PH, and this is partially reversible with acute administration of NO providing therapies. 31 These data support the hypothesis that endothelial dysfunction, and NO deficiency plays an important role in both the pulmonary and systemic vasculature in patients with HFpEF, 35 and that therapies targeting NO metabolism may hold great promise for patients with HFpEF and PVD. Recent data also indicate that there may be substantial pulmonary vascular remodelling in patients with HFpEF, which may require additional antiproliferative therapies to restore pulmonary vascular reserve. 36 Exercise unmasks a unique pathophysiology in heart failure with preserved ejection fraction with pulmonary vascular disease
We observed distinct haemodynamic responses to exercise in HFpEF patients that varied according to the presence or absence of PVD, many of which were related to the phenomenon of ventricular interdependence. We speculate that this was related to two key factors: an inability of the lung vasculature to accommodate increased blood volume and flow due to vasoconstriction and vascular remodelling, and impairments in RV function that limited the ability to eject blood through the higher impedance pulmonary circulation as metabolic demand for systemic perfusion increases. The RV and LV are connected in series, so RV output affects LV filling in this direct way. However, the two ventricles also occupy the same space in the cardiac fossa and may also interact in parallel. [27] [28] [29] Ventricular interdependence refers to the phenomenon whereby changes in pressure, filling, and volume in one chamber influences these characteristics in the other chamber. Diastolic ventricular interaction may be observed in patients with right heart failure due to Exercise poses a profound stress on the heart and lungs: blood is rapidly redistributed from the abdomen and extremities to the thorax, leading in a 50% increase in lung blood volume and 300% increase in pulmonary blood flow in the healthy adult. 15 Because patients with CpcPH-HFpEF display PVD that may limit this reserve, we hypothesized that the increase in systemic venous return accompanying exercise might overwhelm the right heart and lungs, leading to more severe PH, greater RV-PA uncoupling, and heightened rightsided congestion, setting the stage for conditions that promote enhanced interdependence.
Consistent with this hypothesis, we found that lower PA compliance was associated with more exuberant increases in RA pressures in CpcPH-HFpEF patients during exercise (Figure 4) , while greater elevations in PVR and TPG were correlated with greater reduction in LVTMP (Figure 3) , which more accurately reflects the true LV distending pressure or preload. 28, 29 The combination of a reduction in LV transmural distending pressure and blunted RV contractile reserve observed in the CpcPH-HFpEF group led to a striking reduction in stroke volume during exercise and impairment in cardiac output heightened venous return (Figure 4) .
Clinical implications
The treatment of HFpEF is an enormous unmet public health need, and there have been valid concerns that many of the previous neutral trials might have been positive if the right patients had been enrolled. The common existence of PVD in HFpEF and its association with adverse prognosis has stimulated new interest in novel therapies targeting the <0.0001 A-V O 2 difference (mL/dL) 9.5 ± 2.1 9.8 ± 2.6 10.6 ± 2.1 0.3
Data are mean ± standard deviation. Final column reflects overall group differences. No adjustment for multiple hypotheses testing of different variables was performed. BP, blood pressure; CpcPH, combined post-and pre-capillary pulmonary hypertension; Ea-P, pulmonary arterial elastance; Ea-S, systemic arterial elastance; HFpEF, heart failure with preserved ejection fraction; IpcPH, isolated post-capillary pulmonary hypertension; LVTMP, left ventricular transmural pressure; PA, pulmonary artery; PAC, pulmonary arterial compliance; PCWP, pulmonary capillary wedge pressure; PH, pulmonary hypertension; PVR, pulmonary vascular resistance; RA, right atrial; RAP, right atrial pressure; SVR, systemic vascular resistance; TAC, total arterial compliance; TPR, total pulmonary resistance; RVSW, right ventricular stroke work. pulmonary vasculature in this disorder. 6, 7 The present data identifying unique features to the pathophysiology of PVD provide further support for conducting trials targeting pulmonary vascular structure and function in HFpEF. For the design of such therapies, it may be best to first conduct smaller mechanistic, Phases 1 and 2 trials to specifically investigate safety and signals of efficacy for specific drugs, using invasive haemodynamic endpoints. Multiple such trials targeting pulmonary vasoconstriction and remodelling are currently underway (NCT 03153111, 02742129, 03043651, 02885636, 03015402, and 02744339). If candidate drugs demonstrate safety and signal of efficacy in smaller invasive trials, larger clinical trials may then be conducted without the need for invasive haemodynamic phenotyping, using non-invasive surrogate criteria, for example relying upon imaging and biomarkers, and using more easily measurable endpoints such as 6 minute walk distance and quality of life assessment. This sort of staged approach may hold the greatest potential to deliver the right therapy to the patient most likely to derive benefit from this therapy, rather than the 'one size fits all' approach that has been used unsuccessfully thus far in HFpEF.
The current data suggest that there may be other therapeutic targets in HFpEF-PVD that merit study. The enhanced ventricular interdependence that occurs during exercise in HFpEF-PVD provides a theoretical basis for reducing pericardial restraint in order to preserve stroke volume reserve and improve cardiac output, similar to what is observed with pulmonary embolism. 28, 37 In this regard, we have recently shown in animals without PVD that limited anterior pericardial resection abrogates the increase in cardiac filling pressures with volume loading, improving Frank-Starling reserve. 38 However, because pericardial resection can promote eccentric remodelling, 39 and because we observed greater RV dilation with increasing PVR, it might be important to treat PVD in tandem with interventions targeted to the pericardial restraint in patients with HFpEF and PVD. Right ventricular contractile reserve was also impaired with exercise in this study, in agreement with previous studies performed in HFpEF patients without substantial PVD, 25, 40 and this also supports testing new therapies that can improve RV function and functional reserve to improve clinical status in CpcPH-HFpEF. There is controversy on the best method to define the entity of CpcPH. Current guidelines recommend the use of either PVR or DPG criteria. 18 We observed that all of the CpcPH patients displayed elevated PVR, yet only a minority demonstrated an elevated DPG. Prior studies have shown that DPG does not predict survival in HF, 6 and the current data show that DPG is not superior to PVR to identify patients with this characteristic pathophysiology on exercise. Further research is needed to investigate whether other haemodynamic parameters such as PAC may provide added value in this regard.
Limitations
This study was single centre and all patients were referred for right heart catheterization, introducing selection bias. However, the Table S1 ). The inclusion period for the study was extensive, but sensitivity analysis restricted to older and more recently evaluated patients revealed similar results (Supplementary material online, Table S2 ). Although the majority of patients had a quantitative assessment of LV ejection fraction, in a minority of patients LV ejection fraction was assessed qualitatively, and this could compromise the accuracy of LVEF assessment. Echocardiography was not performed during exercise. A relatively small number of patients with significant PVD were included in the analysis, yet multiple significant differences were identified. Adjustment of multiple hypothesis testing was not performed because the haemodynamic indices examined are highly interrelated and not independent of one another. We did not include patients with early stage HFpEF (elevated PCWP during exercise but not at rest), 41 because the PH subtypes are currently only classified based on resting haemodynamics. 18 Further research is needed to characterize pulmonary vascular responses to exercise in patients with early stage HFpEF. 7 
Conclusions
Pulmonary vascular disease in HFpEF leads to unique pathophysiologic consequences during the stress of exercise, including inadequate PA vasodilation, greater right heart congestion, left heart underfilling, heightened ventricular interdependence, and impaired RV reserve. These limitations markedly sabotage the ability of the heart to increase stroke volume and cardiac output during exercise, leading to profound limitations in aerobic capacity. Interventions targeted to this distinct pathophysiology require testing in patients with HFpEF with PVD.
